Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33108
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kelly, Brian D | - |
dc.contributor.author | Perera, Marlon | - |
dc.contributor.author | Bolton, Damien M | - |
dc.contributor.author | Papa, Nathan | - |
dc.date | 2022 | - |
dc.date.accessioned | 2023-06-16T06:48:54Z | - |
dc.date.available | 2023-06-16T06:48:54Z | - |
dc.date.issued | 2023-06 | - |
dc.identifier.citation | Prostate Cancer and Prostatic Diseases 2023; 26(2) | en_US |
dc.identifier.issn | 1476-5608 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/33108 | - |
dc.description.abstract | Socioeconomic status (SES), race and geographical factors are known to impact prostate cancer management and outcomes. We aimed to assess these factors with regard to access to novel imaging in prostate cancer. Using the Prostate Cancer Outcomes Registry of Victoria (PCOR-Vic) we identified 5256 men diagnosed with prostate cancer via biopsy. Following the introduction of government rebate, the access to MRI improved with respect to SES. Access to PET imaging remains poor with respect to SES and geographical location in the absence of Federal funding. Further improvements for men with low SES and regional areas to access PET staging. | en_US |
dc.language.iso | eng | - |
dc.title | Social determinants of health: does socioeconomic status affect access to staging imaging for men with prostate cancer. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Prostate Cancer and Prostatic Diseases | en_US |
dc.identifier.affiliation | Urology | en_US |
dc.identifier.affiliation | Department of Urology, Memorial Sloan Kettering Cancer Center, NYC, NY, USA. | en_US |
dc.identifier.affiliation | Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. | en_US |
dc.identifier.affiliation | School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. | en_US |
dc.identifier.doi | 10.1038/s41391-022-00508-7 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-1138-6389 | en_US |
dc.identifier.orcid | 0000-0002-5145-6783 | en_US |
dc.identifier.pubmedid | 35169274 | - |
dc.description.volume | 26 | - |
dc.description.issue | 2 | - |
dc.description.startpage | 429 | - |
dc.description.endpage | 431 | - |
dc.subject.meshtermssecondary | Prostatic Neoplasms/diagnostic imaging | - |
dc.subject.meshtermssecondary | Prostatic Neoplasms/epidemiology | - |
local.name.researcher | Bolton, Damien M | |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Urology | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Urology | - |
crisitem.author.dept | Urology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.